Even with more restrictive assumptions, the analysis still showed a substantial treatment gap, with only 14.2% of patients ...

Expert Rev Anti Infect Ther. 2011;9(2):215-226. As with most mammalian bites, amoxicillin/clavulanic acid (augmentin) is a reasonable empiric antibiotic in an ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...

The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.